Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | LLY | JNJ |
|---|---|---|
| Price | $1,188.19 | $271.49 |
| Change today | ▲ 3.23% | ▲ 0.86% |
| Market cap | $1.12T | $654.25B |
| Return, 3 months | +6.5% | +13.2% |
| Return, year to date | +11.1% | +33.3% |
| Return, 1 year | +61.2% | +57.1% |
| P/E (TTM) | 39.9 | 31.5 |
| P/B | 33.0 | 7.7 |
| P/E percentile vs own 5y | 5th | 88th |
| Dividend yield | 0.54% | 1.93% |
| Revenue growth (YoY, latest qtr) | +47.7% | +6.6% |
| Net profit growth (YoY) | +25.3% | -0.1% |
| Gross margin | 83.4% | 67.9% |
| Operating margin | 49.7% | 26.8% |
| Net margin | 33.5% | 21.5% |
| Return on equity | 102.4% | 25.7% |
| Analyst target vs. price | +15.5% | +5.6% |
| Analyst buy share | 86% | 78% |
| RSI (14) | 51 | 57 |
| 30-day volatility | 26.1% | 19.0% |
| Max drawdown, 1 year | -23.2% | -11.0% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.